[Troponin and other markers of myocardial ischemia injury, what is the relevance in internal medicine?].
OBJECTIVE
Troponin is now the gold standard for the diagnosis of myocardial infarction. Aiming at improving the management of a patient suspect of an acute coronary syndrome, this article will point the interpretation of troponin dosages according to the clinical presentation and concomitant diseases.
First, the interest of troponin dosage as compared with other markers of myocardial ischemia will be underlined. Then, the literature available about troponin in cardiovascular diseases but also in extracardiac diseases will be analysed. Finally, the difficulties of assay will be discussed.


CONCLUSIONS
The availability of a sensitive and specific marker such as troponin is definitively a progress in the management of patients with an acute coronary syndromes. But it remains a biological contribution to the global management of the patient. It is important to know the causes susceptible to increase the levels of troponin to avoid a wrong interpretation of the dosage, leading to diagnostic but also therapeutic mistakes.
Pruvot
S
S
Service de Médecine A, Hôpital Lariboisière, Paris, France.
Galidie
G
G
Bergmann
J-F
JF
Mahé
I
I
D015415:Biomarkers / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D003937:Diagnosis, Differential; D006801:Humans; D007388:Internal Medicine; D009203:Myocardial Infarction / Q000097:blood* / Q000175:diagnosis; D012680:Sensitivity and Specificity; D014336:Troponin / Q000097:blood*
D015415:Biomarkers; D014336:Troponin; D003402:Creatine Kinase